In comparison, HOXB3 expression decreases with dysplasia, is absent in IPMNs with high‐grade dysplasia, and is therefore a potential marker of low‐grade IPMN [54]. Here, HOXB3 is linked to pancreatic intraductal papillary-mucinous neoplasm.